Drug Shortage Report for DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
| Report ID | 199246 |
| Drug Identification Number | 02194465 |
| Brand name | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP |
| Common or Proper name | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | DOXORUBICIN HYDROCHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVESICAL INTRAVENOUS INTRAVESICAL INTRAVENOUS |
| Packaging size | 25mL vial |
| ATC code | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-08-31 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2023-09-11 |
| Shortage status | Resolved |
| Updated date | 2023-09-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-09-14 | French | Compare |
| v7 | 2023-09-14 | English | Compare |
| v6 | 2023-09-01 | English | Compare |
| v5 | 2023-08-25 | French | Compare |
| v4 | 2023-08-25 | English | Compare |
| v3 | 2023-08-05 | English | Compare |
| v2 | 2023-07-20 | French | Compare |
| v1 | 2023-07-20 | English | Compare |
Showing 1 to 8 of 8